Remove 2022 Remove Drug Research Remove Packaging Remove Regulations
article thumbnail

Article EMA Thank You What we expect European regulators to do in August and September 2024

Agency IQ

What we expect European regulators to do in August and September 2024 In this recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

article thumbnail

Overcoming inefficiencies to improve access to cell and gene therapy 

Drug Discovery World

They can manufacture the drug substance and then pass it to a specialised fill-finish facility that will load it into its final sterile packaging.   Conversely, cell therapy manufacturing starts with a highly heterogeneous source material: human blood. Food and Drug Administration. April 4, 2022. Fraiser Kansteiner.

Therapies 130
article thumbnail

Deliberate Dysentery

Codon

A 2022 survey identified 284 human challenge trials that have been conducted since 1980. With hepatitis C, what changed within the last 10 years was the development of direct-acting antivirals , or DAAs, which are packaged into pills that you can take once a day for a few months. Sign up to receive articles from Asimov Press.

Vaccine 117